The selection of commercially viable drug candidates and advancing their development
toward worldwide markets is a complex and challenging task that requires people with a broad
range of different qualifications and drug development know-how.

Luis Eduardo Caroli

Board member

Back to team

Luis graduated in dentistry and law from universities in Rio de Janeiro and earned an MBA in law. After working for 5 years as a dentist and 3 years as a lawyer, he started working at Delta do Prata, an investment holding company focused on investments in early stage technologies, mostly coming from universities. Luis headed this company from 2003 to 2012 and invested in several companies in the health care area, like Pele Nova Biotecnologia and Excellion a company focused on applied cell therapies. In 2008, Luis took over the operative responsibility for Excelion and served as the CEO and transformed the company from a research and development into a commercial stage company. In 2012 he helped to found Biozeus and serves as the CEO of the company since then.